BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stone GW, Maehara A, Ali ZA, Held C, Matsumura M, Kjøller-Hansen L, Bøtker HE, Maeng M, Engstrøm T, Wiseth R, Persson J, Trovik T, Jensen U, James SK, Mintz GS, Dressler O, Crowley A, Ben-Yehuda O, Erlinge D; PROSPECT ABSORB Investigators. Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. J Am Coll Cardiol 2020;76:2289-301. [PMID: 33069847 DOI: 10.1016/j.jacc.2020.09.547] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 34.0] [Reference Citation Analysis]
Number Citing Articles
1 Buono MF, Slenders L, Wesseling M, Hartman RJG, Monaco C, den Ruijter HM, Pasterkamp G, Mokry M. The changing landscape of the vulnerable plaque: a call for fine-tuning of preclinical models. Vascul Pharmacol 2021;141:106924. [PMID: 34607015 DOI: 10.1016/j.vph.2021.106924] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Serruys PW, Ono M, Garg S, Hara H, Kawashima H, Pompilio G, Andreini D, Holmes DR Jr, Onuma Y, King Iii SB. Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol 2021;78:384-407. [PMID: 34294273 DOI: 10.1016/j.jacc.2021.05.024] [Reference Citation Analysis]
3 Prati F, Arbustini E, Alfonso F. Potential of an Approach Based on the Identification and Treatment of Vulnerable Coronary Plaques. JACC Cardiovasc Interv 2021;14:468-73. [PMID: 33602444 DOI: 10.1016/j.jcin.2020.12.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nicholls SJ, Chandrashekhar YS. Time for Intravascular Plaque Imaging to Connect the Dots From Biology to Therapeutics. JACC Cardiovasc Imaging 2021;14:1490-2. [PMID: 34238541 DOI: 10.1016/j.jcmg.2021.06.001] [Reference Citation Analysis]
5 Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, Engstrøm T, Matsumura M, Crowley A, Dressler O, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Okkels Jensen L, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Muller JE, Stone GW; PROSPECT II Investigators. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet 2021;397:985-95. [PMID: 33714389 DOI: 10.1016/S0140-6736(21)00249-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 19.0] [Reference Citation Analysis]
6 Mol JQ, Belkacemi A, Volleberg RH, Meuwissen M, Protopopov AV, Laanmets P, Krestyaninov OV, Dennert R, Oemrawsingh RM, van Kuijk JP, Arkenbout K, van der Heijden DJ, Rasoul S, Lipsic E, Teerenstra S, Camaro C, Damman P, van Leeuwen MA, van Geuns RJ, van Royen N. Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study. BMJ Open 2021;11:e048994. [PMID: 34233996 DOI: 10.1136/bmjopen-2021-048994] [Reference Citation Analysis]
7 Sagris M, Antonopoulos AS, Theofilis P, Oikonomou E, Siasos G, Tsalamandris S, Antoniades C, Brilakis ES, Kaski JC, Tousoulis D. Risk factors profile of young and older patients with Myocardial Infarction. Cardiovasc Res 2021:cvab264. [PMID: 34358302 DOI: 10.1093/cvr/cvab264] [Reference Citation Analysis]
8 Heinsen LJ, Pararajasingam G, Andersen TR, Auscher S, Sheta HM, Precht H, Lambrechtsen J, Egstrup K. High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score. Cardiovasc Diabetol 2021;20:164. [PMID: 34372839 DOI: 10.1186/s12933-021-01350-2] [Reference Citation Analysis]
9 Pasterkamp G, van der Harst P, den Ruijter HM. Preemptive Stenting of the Vulnerable Plaque: Fixing a Dogma? J Am Coll Cardiol 2020;76:2302-4. [PMID: 33183503 DOI: 10.1016/j.jacc.2020.09.600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Renkens MPL, Mintz GS, Torguson R, Di Mario C, Ten Cate T, Ali ZA, Singh V, Skinner W, Artis A, Garcia-Garcia HM, de Winter RJ, Wykrzykowska JJ, Waksman R. Non-culprit MACE-rate in LRP: The influence of optimal medical therapy using DAPT and statins. Cardiovasc Revasc Med 2021:S1553-8389(21)00522-4. [PMID: 34303625 DOI: 10.1016/j.carrev.2021.07.015] [Reference Citation Analysis]
11 Doenst T, Bonow RO, Bhatt DL, Falk V, Gaudino M. Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week. J Am Coll Cardiol 2021;78:180-8. [PMID: 34238439 DOI: 10.1016/j.jacc.2021.05.010] [Reference Citation Analysis]
12 Wu X, Wu S, Kawashima H, Hara H, Ono M, Gao C, Wang R, Lunardi M, Sharif F, Wijns W, Serruys PW, Onuma Y. Current perspectives on bioresorbable scaffolds in coronary intervention and other fields. Expert Rev Med Devices 2021;18:351-65. [PMID: 33739213 DOI: 10.1080/17434440.2021.1904894] [Reference Citation Analysis]
13 Andò G, D'Ascenzo F. Instantaneous wave-free ratio during primary percutaneous coronary intervention: life is simple, and the simple thing is the right thing. Minerva Cardiol Angiol 2021;69:288-90. [PMID: 33703867 DOI: 10.23736/S2724-5683.21.05628-0] [Reference Citation Analysis]
14 Alfonso F, Gonzalo N, Rivero F, Escaned J. The year in cardiovascular medicine 2020: interventional cardiology. Eur Heart J 2021;42:985-1003. [PMID: 33448291 DOI: 10.1093/eurheartj/ehaa1096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fuster V. Editor-in-Chief's Top Picks From 2020. J Am Coll Cardiol 2021;77:937-97. [PMID: 33602476 DOI: 10.1016/j.jacc.2020.12.044] [Reference Citation Analysis]
16 Takahashi N, Dohi T, Endo H, Takeuchi M, Doi S, Kato Y, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Minamino T. Coronary lipid-rich plaque characteristics in Japanese patients with acute coronary syndrome and stable angina: A near infrared spectroscopy and intravascular ultrasound study. Int J Cardiol Heart Vasc 2021;33:100747. [PMID: 33748401 DOI: 10.1016/j.ijcha.2021.100747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Del Buono MG, Montone RA, Iannaccone G, Rinaldi R, La Vecchia G, Camilli M, Gurgoglione FL, Russo M, Lombardi M, D'amario D, Niccoli G. Redefining residual inflammatory risk after acute coronary syndrome. Future Cardiol 2021. [PMID: 34397269 DOI: 10.2217/fca-2021-0032] [Reference Citation Analysis]
18 Kefer J, Chenu P, Gurné O, Maes F, Tamakloé T, Beauloye C. Reduction of Lipid-Core Burden Index in Nonculprit Lesions at Follow-Up after ST-Elevation Myocardial Infarction: A Randomized Study of Bioresorbable Vascular Scaffold versus Optimal Medical Therapy. J Interv Cardiol 2021;2021:5590093. [PMID: 34290573 DOI: 10.1155/2021/5590093] [Reference Citation Analysis]
19 Refahiyat L, Madder RD. In Search of a Blood Marker for Vulnerable Plaque. Cardiovasc Revasc Med 2021;32:11-2. [PMID: 34412990 DOI: 10.1016/j.carrev.2021.08.006] [Reference Citation Analysis]
20 Tomaniak M, Ochijewicz D, Kołtowski Ł, Rdzanek A, Pietrasik A, Jąkała J, Slezak M, Malinowski KP, Zaleska M, Maksym J, Barus P, Roleder T, Filipiak KJ, Opolski G, Kochman J. OCT-Derived Plaque Morphology and FFR-Determined Hemodynamic Relevance in Intermediate Coronary Stenoses. J Clin Med 2021;10:2379. [PMID: 34071299 DOI: 10.3390/jcm10112379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kuku KO, Garcia-Garcia HM, Doros G, Mintz GS, Ali ZA, Skinner WH, Artis AK, Ten Cate T, Powers E, Wong SC, Wykrzykowska J, Dube S, Kazziha S, van der Ent M, Shah P, Sum S, Torguson R, Di Mario C, Waksman R; LRP Investigators. Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study. Eur Heart J Cardiovasc Imaging 2021:jeab160. [PMID: 34410335 DOI: 10.1093/ehjci/jeab160] [Reference Citation Analysis]
22 Binder CJ, Borén J, Catapano A, Kronenberg F, Mallat Z, Negrini S, Öörni K, Raggi P, von Eckardstein A. The year 2020 in Atherosclerosis. Atherosclerosis 2021;326:35-44. [PMID: 33958158 DOI: 10.1016/j.atherosclerosis.2021.04.013] [Reference Citation Analysis]
23 Lin L, Xie Z, Xu M, Wang Y, Li S, Yang N, Gong X, Liang P, Zhang X, Song L, Cao F. IVUS\IVPA hybrid intravascular molecular imaging of angiogenesis in atherosclerotic plaques via RGDfk peptide-targeted nanoprobes. Photoacoustics 2021;22:100262. [PMID: 33868920 DOI: 10.1016/j.pacs.2021.100262] [Reference Citation Analysis]
24 Kearney A, Linden K, Savage P, Menown IBA. Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials. Adv Ther 2021;38:2170-200. [PMID: 33844133 DOI: 10.1007/s12325-021-01711-z] [Reference Citation Analysis]
25 Kunkel KJ, Lemor A, Mahmood S, Villablanca P, Ramakrishna H. 2021 Update for the Diagnosis and Management of Acute Coronary Syndromes for the Perioperative Clinician. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00613-3. [PMID: 34400062 DOI: 10.1053/j.jvca.2021.07.032] [Reference Citation Analysis]
26 Leng J, Zhang J, Li C, Shu C, Wang B, Lin R, Liang Y, Wang K, Shen L, Lam KH, Xie Z, Gong X, Ge J, Song L. Multi-spectral intravascular photoacoustic/ultrasound/optical coherence tomography tri-modality system with a fully-integrated 0.9-mm full field-of-view catheter for plaque vulnerability imaging. Biomed Opt Express 2021;12:1934-46. [PMID: 33996208 DOI: 10.1364/BOE.420724] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Li J, Montarello NJ, Hoogendoorn A, Verjans JW, Bursill CA, Peter K, Nicholls SJ, McLaughlin RA, Psaltis PJ. Multimodality Intravascular Imaging of High-Risk Coronary Plaque. JACC Cardiovasc Imaging 2021:S1936-878X(21)00343-0. [PMID: 34023267 DOI: 10.1016/j.jcmg.2021.03.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]